Peel Hunt reaffirmed their hold rating on shares of Spire Healthcare Group (LON:SPI) in a report released on Thursday morning, ThisIsMoney.Co.Uk reports.
A number of other equities research analysts have also weighed in on SPI. JPMorgan Chase & Co. set a €21.00 ($24.42) price objective on Signify and gave the stock a sell rating in a research report on Monday, March 25th. Credit Suisse Group set a €201.00 ($233.72) price objective on Volkswagen and gave the stock a buy rating in a research report on Wednesday, March 13th. UBS Group set a $54.00 price objective on Westlake Chemical and gave the stock a sell rating in a research report on Tuesday, July 2nd. Numis Securities restated a buy rating on shares of 3i Group in a research note on Thursday, May 16th. Finally, Barclays lowered their target price on BT Group from GBX 250 ($3.27) to GBX 240 ($3.14) and set an equal weight rating for the company in a research note on Friday, May 10th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of GBX 127.78 ($1.67).
Shares of SPI stock opened at GBX 111.60 ($1.46) on Thursday. The company has a market cap of $447.61 million and a price-to-earnings ratio of 39.86. Spire Healthcare Group has a fifty-two week low of GBX 96.15 ($1.26) and a fifty-two week high of GBX 259.20 ($3.39). The stock has a 50 day simple moving average of GBX 120.72. The company has a current ratio of 1.44, a quick ratio of 0.95 and a debt-to-equity ratio of 48.52.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Featured Article: Trading on Margin
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.